-
Medical Updates"Spiral Escalation–De-escalation" Therapy for End-stage Heart Failure Recognized as a Major Clinical Technology in Guangzhou 2025-10-25
-
IndustryShowcasing magAssist's Extracorporeal Support Solutions at 36th Annual ELSO Conference 2025-09-30
-
CorporatemagAssist Recognized as a 2025 Potential Unicorn Enterprise in Jiangsu 2025-09-30
-
Medical UpdatesVentricular Assist Device Support for High-Risk PCI in a Patient with Acute Myocardial Infarction and Cardiogenic Shock 2025-09-26
-
Medical UpdatesA Case Report: Use of Ventricular Assist Device to Enable High-Risk PCI in a Patient with Severe Left Ventricular Dysfunction 2025-09-07
-
IndustryAcademic Symposium at Zhujiang Hospital Highlights Advances in Heart Failure Treatment with Extracorporeal VAD 2025-08-15
-
CorporatemagAssist Shortlisted for 2025 Prix Galien USA Best Start-Up Award 2025-08-14
-
Medical UpdatesZhujiang Hospital Transitions from ECMO + IABP to MoyoAssist® in the Management of Cardiogenic Shock 2025-04-30
-
Medical UpdatesRapid Postoperative Recovery Achieved with MoyoAssist® in High-Risk Cardiac Surgery 2025-04-12
-
Medical UpdatesHigh-Risk Coronary Revascularization Supported by MoyoAssist® Magnetic Levitation 2025-04-02
- Technology
- Patent
- Fluid Dynamics
- Full Magnetic Levitated Rotor
- Mechatronics
- Product Manufacturing
- Artificial Hearts
WeChat
Copyright © 2022-2026 magAssist Co., Ltd. All Rights Reserved
